Skip to main content
search
Main navigation
Home
About
About ACSH
Financials
Our Team
Donate
Publications
Media/Contact
Subscribe
Write For Us
antiviral drug research
email
facebook
twitter
linkedin
pocket
reddit
print
China Claims an AIDS Drug Will Beat Covid. Too Good to Be True?
An article in The People's Daily Online, China's largest newspaper, reports that Azvudine (aka FNC), a reverse transcriptase inhibitor (1) – is be
Read more
Pfizer's COVID Pill Ought to Work. Here's Why. (And Some Good News About Merck's Molnupiravir)
As Professor Katherine Seley-Radtke (1) and I wrote last July in an op
Read more
Subscribe to antiviral drug research
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
DONATE
Popular articles
Friday Frauds: Gatorade's Worthless Alkaline Water
Sugar-Sweetened Beverages: What's the Real Impact?
When Doctors Defy Oversight by Licensing Boards: A Fraudulent Use of the First Amendment
'Food Rules' to Food Reality: Machine Learning Unveils Ultra-Processed Truth in Grocery Carts
Pharma Sleaze: Advil Bait and Switch
ACSH Podcasts
Podcast: Is Obesity a Disease? It's Complicated
Podcast: Cookie-Cutter Nutrition – The Problem with USDA's Thrifty Food Plan
Podcast: RFK, Jr. Poised to Run HHS. Public Health Apocalypse Imminent?
Podcast: Mayo Clinic's Nonsense Anti-Opioid Study
Podcast: Everything You Wanted to Know About NSAIDs
More podcasts
Latest from Henry
The Media and I: Fluoridation
FDA’s Failures in the Infant Formula Debacle Cry Out for Reform
The Media and I: Avian Influenza and Unpasteurized Milk
How Close Are We to the Avian Flu Outbreak Escalating Into a Pandemic?
More articles
Latest from Josh
Pharma Sleaze: Advil Bait and Switch
AIDS Denialism Was Rejected Long Ago. It May Be Back
Elderberry Craze Reminiscent of Laetrile Cancer Sham
A Little About Lithium
More articles
Latest from Chuck
What I'm Reading (Jan. 30)
Soda Taxes: Less Soda, Same Waistlines
Fluoridation on Trial: Court Rules on Fluoride’s Risk to Public Health
Snack Attack: FDA Looks to Front-of-Package Labels
More articles